AGP Executive Report
Last update: 4 hours agoDrug Advertising: The U.K. advertising watchdog banned promotions for oral weight-loss drugs that ran before approval or advertised prescription-only medicines to the public, warning that misleading claims can put patients at risk. Medicare: About 20.8 million people with Original Medicare are due a one-time $90 payment toward Part B premiums; Medicare Advantage members and many low-income beneficiaries are excluded. Annual enrollment starts Oct. 15. AI Prescribing: Utah authorized a pilot allowing Nolla Health’s AI system to issue initial acne prescriptions, with physician involvement and a first phase limited to 100 patients. Medicaid Oversight: A Rhode Island audit found all 100 opioid-treatment claims it reviewed failed to meet requirements and flagged nearly $876,000 in possible overpayments. Pharma Research: Australia’s CSIRO and Moderna launched a five-year partnership to speed infectious-disease research and mRNA responses to future biosecurity threats. Pharmacy Business: Canada’s Weston family and Fairfax agreed to buy U.K. chain Boots for $8.9 billion, including its U.K. and Ireland stores, opticians and No7 beauty business.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
